Dziak Kathleen, Anderson Roger, Sevick Mary Ann, Weisman Carol S, Levine Douglas W, Scholle Sarah Hudson
Research and Analysis, National Committee for Quality Assurance, Washington, DC 20036, USA.
Health Serv Res. 2005 Feb;40(1):279-90. doi: 10.1111/j.1475-6773.2005.00353.x.
To document the Institutional Review Board (IRB) review process and to explore the impact of different patient notification procedures.
DATA SOURCES/STUDY SETTING: Review of IRB application and correspondence records prospectively collected during a multisite study of health care quality involving telephone interviews of 3,000 participants across 15 primary care sites.
Records were reviewed to ascertain: (1) the type of IRB review conducted, (2) the number of days from submission to approval of the IRB application, (3) whether the IRB required patient notification and/or consent prior to the release of names, and (4) patient participation rates.
DATA COLLECTION/EXTRACTION METHODS: The study coordinating center prepared a common study protocol for IRB submission and assisted sites with submission. The application, correspondence with the IRB, consent script, and patient letters were collected, reviewed, coded, and analyzed.
IRBs at the 15 sites and survey center varied in the type of IRB required and the number of days from submission to approval (range of 5-172 days). Four sites required patient notification in advance of the study; 2-11 percent of patients refused in opt-out sites and 37 percent in the single opt-in site. Participation among contacted patients did not appear to be related to patient notification procedures.
Variations in IRB requirements can affect response rates and sample generalizability.
记录机构审查委员会(IRB)的审查过程,并探讨不同患者通知程序的影响。
数据来源/研究背景:回顾在一项涉及对15个初级保健机构的3000名参与者进行电话访谈的医疗质量多中心研究中前瞻性收集的IRB申请及通信记录。
对记录进行审查以确定:(1)进行的IRB审查类型;(2)IRB申请从提交到批准的天数;(3)IRB在公布姓名之前是否要求患者通知和/或同意;(4)患者参与率。
数据收集/提取方法:研究协调中心制定了一份通用的IRB提交研究方案,并协助各机构进行提交。收集、审查、编码和分析了申请、与IRB的通信、同意书脚本和患者信件。
15个机构和调查中心的IRB在所需的IRB类型以及从提交到批准的天数方面存在差异(范围为5 - 172天)。四个机构在研究前要求患者通知;在退出式机构中2% - 11%的患者拒绝,在单一加入式机构中37%的患者拒绝。被联系患者的参与情况似乎与患者通知程序无关。
IRB要求的差异会影响回复率和样本的普遍性。